Document Detail


Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
MedLine Citation:
PMID:  23416953     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Alterations in microRNA (miRNA) expression have been described in thyroid tumors, suggesting a role for miRNAs in thyroid carcinogenesis. BRAF(V600E) is the most frequently identified genetic alteration in papillary thyroid carcinoma (PTC). We investigated the link between BRAF(V600E) status and the expression of miRNAs in PTC and analyzed the associations of these factors with clinicopathological characteristics.
DESIGN AND METHODS: Prospective study of patients who underwent thyroid surgery between October 8, 2008 and November 1, 2010. BRAF(V600E) status was determined by mutant allele-specific amplification PCR and direct sequencing of exon 15 of the BRAF gene in 69 PTC tissues and 69 respective paracancerous normal thyroid tissues. Initially, miRNA expression was analyzed in 12 PTC tissues and three associated paracancerous tissues using a miRNA microarray. miRNAs differentially expressed between BRAF(V600E)-positive and -negative PTC tissues were then validated by real-time quantitative PCR on 69 PTC tissues and 69 paracancerous tissues. We also explored the associations between BRAF(V600E) status or differential miRNA expression and clinicopathological characteristics.
RESULTS: The mutation rate of BRAF(V600E) in PTC was 47.8%. Twelve miRNAs were upregulated and six were downregulated in PTC tissues, among which miR-15a, 15a*, 34a*, 34b*, 551b, 873, 876-3p, and 1274a were first identified. miR-21* and 203 were significantly dysregulated (P<0.05) in PTC tissues with BRAF(V600E). Additionally, there were significant associations (P<0.05) between BRAF(V600E) and a higher tumor-node-metastasis staging (III/IV), and between miR-21* over-expression and lymph node metastasis.
CONCLUSIONS: We identified two miRNAs that are differentially expressed in PTC tissues with BRAF(V600E) and revealed their associations with clinicopathological features. These findings may lead to the development of a potential diagnostic biomarker or prognostic indicator of PTC.
Authors:
Yongbo Huang; Denghui Liao; Lingxiao Pan; Runyi Ye; Xiaoxi Li; Shenming Wang; Caisheng Ye; Liuhua Chen
Related Documents :
15051733 - The p75ntr-interacting protein sc1 inhibits cell cycle progression by transcriptional r...
23600383 - Alteration in p-glycoprotein at the blood-brain barrier in the early period of mcao in ...
10797183 - Hypertonic mannitol loading of nf-kappab transcription factor decoys in human brain mic...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2013-04-15
Journal Detail:
Title:  European journal of endocrinology / European Federation of Endocrine Societies     Volume:  168     ISSN:  1479-683X     ISO Abbreviation:  Eur. J. Endocrinol.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-16     Completed Date:  2013-06-06     Revised Date:  2013-07-19    
Medline Journal Info:
Nlm Unique ID:  9423848     Medline TA:  Eur J Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  675-81     Citation Subset:  IM    
Affiliation:
Department of Vascular and Thyroid Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Alleles
Carcinoma, Papillary / genetics*,  metabolism,  pathology
Female
Humans
Male
MicroRNAs / genetics*,  metabolism
Middle Aged
Mutation*
Prognosis
Prospective Studies
Proto-Oncogene Proteins B-raf / genetics*
Thyroid Neoplasms / genetics*,  metabolism,  pathology
Tumor Markers, Biological / genetics
Chemical
Reg. No./Substance:
0/MicroRNAs; 0/Tumor Markers, Biological; EC 2.7.11.1/BRAF protein, human; EC 2.7.11.1/Proto-Oncogene Proteins B-raf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type I.
Next Document:  High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon ...